Cargando…
Preparation and drug delivery of dextran-drug complex
Dextran as a drug carrier for inhibiting cancer cells effectively reduces the toxic and side effects of the drug in the biological body. Targeting improves the concentration of active substance around the target tissue, which reduces damage to other heavy organs and other normal tissues. Dextran wil...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419624/ https://www.ncbi.nlm.nih.gov/pubmed/30857442 http://dx.doi.org/10.1080/10717544.2019.1580322 |
_version_ | 1783403982911176704 |
---|---|
author | Huang, Shiyu Huang, Gangliang |
author_facet | Huang, Shiyu Huang, Gangliang |
author_sort | Huang, Shiyu |
collection | PubMed |
description | Dextran as a drug carrier for inhibiting cancer cells effectively reduces the toxic and side effects of the drug in the biological body. Targeting improves the concentration of active substance around the target tissue, which reduces damage to other heavy organs and other normal tissues. Dextran will be a potential carrier for the delivery of antitumor drugs in the future, which provides the possibility of slow-release chemotherapy and targeted drug delivery. Herein, the preparation and drug delivery of dextran-drug complex were summarized and discussed in detail. |
format | Online Article Text |
id | pubmed-6419624 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-64196242019-03-19 Preparation and drug delivery of dextran-drug complex Huang, Shiyu Huang, Gangliang Drug Deliv Review Article Dextran as a drug carrier for inhibiting cancer cells effectively reduces the toxic and side effects of the drug in the biological body. Targeting improves the concentration of active substance around the target tissue, which reduces damage to other heavy organs and other normal tissues. Dextran will be a potential carrier for the delivery of antitumor drugs in the future, which provides the possibility of slow-release chemotherapy and targeted drug delivery. Herein, the preparation and drug delivery of dextran-drug complex were summarized and discussed in detail. Taylor & Francis 2019-03-11 /pmc/articles/PMC6419624/ /pubmed/30857442 http://dx.doi.org/10.1080/10717544.2019.1580322 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Huang, Shiyu Huang, Gangliang Preparation and drug delivery of dextran-drug complex |
title | Preparation and drug delivery of dextran-drug complex |
title_full | Preparation and drug delivery of dextran-drug complex |
title_fullStr | Preparation and drug delivery of dextran-drug complex |
title_full_unstemmed | Preparation and drug delivery of dextran-drug complex |
title_short | Preparation and drug delivery of dextran-drug complex |
title_sort | preparation and drug delivery of dextran-drug complex |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419624/ https://www.ncbi.nlm.nih.gov/pubmed/30857442 http://dx.doi.org/10.1080/10717544.2019.1580322 |
work_keys_str_mv | AT huangshiyu preparationanddrugdeliveryofdextrandrugcomplex AT huanggangliang preparationanddrugdeliveryofdextrandrugcomplex |